New Owner
Mylan Technologies - Merck Generics
Mylan Technologies acquires Merck Generics
Announced: May 12, 2007
Type: Acquisition
Disposition: Subsidiary
Terms: Cash
Status: Complete
Amount: $ 6,700,000,000